Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05089773 |
Other study ID # |
TGA-CTS |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
December 1, 2019 |
Est. completion date |
April 30, 2020 |
Study information
Verified date |
March 2021 |
Source |
Children's Hospital of Fudan University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Transposition of the great arteries (TGA) is a complex cyanotic congenital heart disease and
patients suffer from a high mortality rate within one year of age without appropriate
management. The therapeutic effect of arterial switch operation (ASO) is satisfactory with
low surgery mortality of 2-5%, and thus, has become the treatment of choice for surgical
correction of d-TGA. Outcomes of ASO in TGA in china are rare. This is a retrospective study
reporting the outcomes of ASO in TGA.
Description:
Transposition of the Great Arteries (TGA) is a relatively rare congenital heart disease and
surgical treatment in China was developed in recent 20 years. The outcomes of arterial switch
operation (ASO) in TGA in China have not been reported before. This study was designed to
offer the experience of surgical treatment of TGA in two major pediatric heart centers
affiliated in national children's medical center in China. In this retrospective study, a
total of 1281 patients diagnosed with TGA received ASO treatment in Fudan Children's Hospital
and Shanghai Children's Medical Center were recruited. Medical records and follow-up data of
patients were complete. Patient characteristics and clinical data were obtained through
review of the medical records, preoperative echocardiography and cardiac catheterization
data, operative notes, and follow up reports. Description of the anatomy was confirmed on the
preoperative echocardiogram, with clarification from the operative note as needed. Anatomy of
the coronary arteries were collected based on the surgical notes. Perioperative data included
aorta cross clamping time, cardiopulmonary bypass time and the application of Lecompete
maneuver.
Early postoperative complications are defined as delayed sternal closure, active bleeding
after surgery, pulmonary artery stenosis, coronary artery re-transplantation, residual
ventricular septal defect with significant shunt, atrioventricular block, extracorporeal
membrane oxygenation support, cardiac arrest, necrotizing enterocolitis and diaphragmatic
eventration. Hospital death was defined as death occurred before discharge.
Follow-up results included echocardiography, cardiac CTA, cardiac catheterization, and
angiography. Echocardiographic assessment included color, continuous wave, and pulse wave
Doppler date for all valves. Peak pressure gradient of 20mmHg was considered to be stenotic
for neoaortic and pulmonary valve. Redo-procedure was defined as any kind of cardiovascular
intervention after the ASO procedure including surgery or catheter-based procedure. The
indication for reintervention of pulmonary or suprapulmonary stenosis was peak pressure
gradient over 40mmHg. Pressure gradient across the LVOT or aortic valve over 50 mmHg was the
indication for reintervention. Late death was defined as death occurred during follow up.
Relationships between preoperative and perioperative factors and hospital mortality were
evaluated.